litlas
Log inCreate account

Willem E. Fibbe

Active 1986–2023

75
Papers
23,913
Citations
67
h-index
75
i10-index

Citations

Citations per year for Willem E. Fibbe1984: 1 citations1989: 5 citations1990: 8 citations1991: 5 citations1992: 6 citations1993: 9 citations1994: 15 citations1995: 18 citations1996: 20 citations1997: 20 citations1998: 39 citations1999: 52 citations2000: 72 citations2001: 53 citations2002: 68 citations2003: 93 citations2004: 69 citations2005: 91 citations2006: 112 citations2007: 196 citations2008: 232 citations2009: 311 citations2010: 360 citations2011: 355 citations2012: 348 citations2013: 382 citations2014: 277 citations2015: 300 citations2016: 291 citations2017: 256 citations2018: 260 citations2019: 769 citations2020: 788 citations2021: 670 citations2022: 501 citations2023: 328 citations2024: 404 citations2025: 157 citations2026: 2 citations1985–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,931 citing papers, 21.3% of this breakdownChina: 995 citing papers, 11% of this breakdownUnited Kingdom: 568 citing papers, 6.3% of this breakdownItaly: 554 citing papers, 6.1% of this breakdownGermany: 513 citing papers, 5.7% of this breakdownNetherlands: 444 citing papers, 4.9% of this breakdownFrance: 380 citing papers, 4.2% of this breakdownCanada: 287 citing papers, 3.2% of this breakdownJapan: 264 citing papers, 2.9% of this breakdownSpain: 261 citing papers, 2.9% of this breakdownSouth Korea: 210 citing papers, 2.3% of this breakdownSwitzerland: 186 citing papers, 2% of this breakdown
0%21.3%Other 27.2%

Institutions

Fields

  • Medicine72.9%
  • Biochemistry, Genetics and Molecular Biology14.4%
  • Immunology and Microbiology9.1%
  • Engineering1.2%
  • Neuroscience1.2%
  • Materials Science0.5%
  • Other0.7%

Topics

  • Mesenchymal stem cell research17.9%
  • Tissue Engineering and Regenerative Medicine6.6%
  • Hematopoietic Stem Cell Transplantation3.4%
  • Extracellular vesicles in disease3.4%
  • Immune Cell Function and Interaction2.3%
  • Cancer Cells and Metastasis2.1%
  • Other64.3%

Coauthors

All papers

Open in search
  1. Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation

    Authors: Maria Ester Bernardo, Willem E. Fibbe - Cell stem cell 2013 cited by 1,389

  2. Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

    Authors: Jacob M. van Laar, Dominique Farge, Jacob K. Sont, Kamran Naraghi, Zora Marjanovic, Jérôme Larghero, Annemie J. Schuerwegh, Erik W.A. Marijt, Madelon C. Vonk, A Schattenberg, Marco Matucci‐Cerinic, Alexandre E. Voskuyl, Arjan A. van de Loosdrecht, Thomas Daikeler, Ina Kötter, Marc Schmalzing, Thierry Martin, Bruno Lioure, Stefan M. Weiner, Alexander Kreuter, C. Deligny, J.M. Durand, Paul Emery, Klaus Machold, F. Sarrot-Reynauld, Klaus Warnatz, D. Adoué, J. Constans, Hans‐Peter Tony, Nicoletta Del Papa, Αthanasios Fassas, Andrea Himsel, David Launay, Andrea Lo Monaco, Pierre Philippe, I. Quéré, Éric Rich, René Westhovens, Bridget Griffiths, Riccardo Saccardi, F.H.J. van den Hoogen, Willem E. Fibbe, Gèrard Socié, Aloïs Gratwohl, A Tyndall - JAMA 2014 cited by 744

  3. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

    Authors: Katarina Le Blanc, Francesco Frassoni, Lynne M. Ball, Franco Locatelli, Helene Roelofs, Ian A. Lewis, Edoardo Lanino, Berit Sundberg, Maria Ester Bernardo, Mats Remberger, Giorgio Dini, R. Maarten Egeler, Andrea Bacigalupo, Willem E. Fibbe, Olle Ringdén - The Lancet 2008 cited by 2,706

  4. International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

    Authors: Jacques Galipeau, Mauro Krampera, John Barrett, Francesco Dazzi, Robert Deans, Joost DeBruijn, Massimo Dominici, Willem E. Fibbe, Adrian P. Gee, J. M. Gimble, Peiman Hematti, Mickey Koh, Katarina LeBlanc, Iván Martín, Ian McNiece, Michael Mendicino, Steve Oh, Luis A. Ortiz, Donald G. Phinney, Valérie Planat‐Benard, Yufang Shi, David F. Stroncek, Sowmya Viswanathan, Daniel J. Weiss, Luc Sensebé - Cytotherapy 2015 cited by 516

  5. Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)

    Authors: Norberto Perico, Giuseppe Remuzzi, Matthew D. Griffin, Paul Cockwell, Alexander P. Maxwell, Federica Casiraghi, Nadia Rubis, Tobia Peracchi, Alessandro Villa, Marta Todeschini, Fabiola Carrara, Bernadette A. Magee, Piero Ruggenenti, Stefano Rota, Laura Cappelletti, Veronica McInerney, Tomás P. Griffin, Md Nahidul Islam, Martino Introna, Olga Pedrini, Josée Golay, A. Finnerty, Jon Smythe, Willem E. Fibbe, Stephen J. Elliman, Timothy O’Brien - Journal of the American Society of Nephrology 2023 cited by 92

  6. Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived Counterparts

    Authors: Sara M. Melief, Jaap Jan Zwaginga, Willem E. Fibbe, Helene Roelofs - Stem Cells Translational Medicine 2013 cited by 446

  7. Risk of tumorigenicity in mesenchymal stromal cell–based therapies—Bridging scientific observations and regulatory viewpoints

    Authors: Lisbeth Barkholt, Egbert Flory, Veronika Jekerle, Sophie Lucas-Samuel, Peter Ahnert, Louise Bisset, Dirk Büscher, Willem E. Fibbe, Arnaud Foussat, Marcel Kwa, Olivier Lantz, Romaldas Mačiulaitis, Tiina Palomäki, Christian K. Schneider, Luc Sensebé, Gérard Tachdjian, Karin Tarte, Lucie Tosca, Paula Salmikangas - Cytotherapy 2013 cited by 409

  8. Immunomodulatory properties of mesenchymal stromal cells

    Authors: Alma J. Nauta, Willem E. Fibbe - Blood 2007 cited by 1,786

  9. Allogeneic Bone Marrow–Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn’s Disease

    Authors: Ilse Molendijk, Bert A. Bonsing, Helene Roelofs, Koen Peeters, Martin N.J.M. Wasser, Gerard Dijkstra, C. Janneke van der Woude, Marjolijn Duijvestein, Roeland A. Veenendaal, Jaap Jan Zwaginga, Hein W. Verspaget, Willem E. Fibbe, Andrea E. van der Meulen‐de Jong, Daniël W. Hommes - Gastroenterology 2015 cited by 339

  10. Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn’s Disease Perianal Fistulas

    Authors: Marieke C. Barnhoorn, Martin N.J.M. Wasser, Helene Roelofs, Jeroen Maljaars, Ilse Molendijk, Bert A. Bonsing, Liesbeth E.M. Oosten, Gerard Dijkstra, C. Janneke van der Woude, Dave L. Roelen, Jaap Jan Zwaginga, Hein W. Verspaget, Willem E. Fibbe, Daniël W. Hommes, Koen Peeters, Andrea E. van der Meulen‐de Jong - Journal of Crohn s and Colitis 2019 cited by 137

  11. Pretreatment with Interferon-γ Enhances the Therapeutic Activity of Mesenchymal Stromal Cells in Animal Models of Colitis

    Authors: Marjolijn Duijvestein, Manon E. Wildenberg, Mick M. Welling, Simone D. Hennink, Ilse Molendijk, Vanessa L. van Zuylen, Tjalling Bosse, Anne Christine W. Vos, Eveline S. M. de Jonge‐Muller, Helene Roelofs, Louise van der Weerd, Hein W. Verspaget, Willem E. Fibbe, Anje A. te Velde, Gijs R. van den Brink, Daniël W. Hommes - Stem Cells 2011 cited by 332

  12. Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta

    Authors: Pieternella S. in `t Anker, Sicco A. Scherjon, Carin Kleijburg‐van der Keur, Godelieve M.J.S. de Groot‐Swings, Frans H.J. Claas, Willem E. Fibbe, Humphrey H.H. Kanhai - Stem Cells 2004 cited by 1,191

  13. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

    Authors: Marjolijn Duijvestein, Anne Christine W. Vos, Helene Roelofs, Manon E. Wildenberg, Barbara B. Wendrich, Henricus W Verspaget, Engelina M C Kooy-Winkelaar, Frits Koning, Jaap Jan Zwaginga, Herma H. Fidder, Auke P. Verhaar, Willem E. Fibbe, Gijs R. van den Brink, Daniël W. Hommes - Gut 2010 cited by 623

  14. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages

    Authors: Sara M. Melief, Ellen Schrama, Martijn H. Brugman, Machteld M. Tiemessen, Martin J. Hoogduijn, Willem E. Fibbe, Helene Roelofs - Stem Cells 2013 cited by 400

  15. Defining the risks of mesenchymal stromal cell therapy

    Authors: Darwin J. Prockop, Malcolm K. Brenner, Willem E. Fibbe, Edwin M. Horwitz, Katarina Le Blanc, Donald G. Phinney, Paul J. Simmons, Luc Sensebé, Armand Keating - Cytotherapy 2010 cited by 351

  16. Human fetal lymphoid tissue–inducer cells are interleukin 17–producing precursors to RORC+ CD127+ natural killer–like cells

    Authors: Tom Cupedo, Natasha K. Crellin, Natalie Papazian, Elwin Rombouts, Kees Weijer, Jane L. Grogan, Willem E. Fibbe, Jan J. Cornelissen, Hergen Spits - Nature Immunology 2008 cited by 650

  17. Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study

    Authors: Marlies E. J. Reinders, Johan W. de Fijter, Helene Roelofs, Ingeborg M. Bajema, Dorottya K. de Vries, Alexander F. Schaapherder, Frans H.J. Claas, Paula P.M.C. van Miert, Dave L. Roelen, Cees van Kooten, Willem E. Fibbe, Ton J. Rabelink - Stem Cells Translational Medicine 2013 cited by 363

  18. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

    Authors: Alma J. Nauta, Geert Westerhuis, Alwine B. Kruisselbrink, Ellie G.A. Lurvink, Roel Willemze, Willem E. Fibbe - Blood 2006 cited by 698

  19. Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid‐refractory, grade III–IV acute graft‐versus‐host disease

    Authors: Lynne M. Ball, Maria Ester Bernardo, Helene Roelofs, Maarten J. D. van Tol, Benedetta Contoli, Jaap Jan Zwaginga, Maria Antonietta Avanzini, Antonella Conforti, Alice Bertaina, Giovanna Giorgiani, Cornelia M. Jol‐van der Zijde, Marco Zecca, Katarina Le Blanc, Francesco Frassoni, R. Maarten Egeler, Willem E. Fibbe, Arjan C. Lankester, Franco Locatelli - British Journal of Haematology 2013 cited by 233

  20. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation

    Authors: Pieternella S. in `t Anker, Sicco A. Scherjon, Carin Kleijburg‐van der Keur, Willy A. Noort, Frans H.J. Claas, R. Willemze, Willem E. Fibbe, Humphrey H.H. Kanhai - Blood 2003 cited by 809

  21. Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6

    Authors: Sara M. Melief, Sacha B. Geutskens, Willem E. Fibbe, Helene Roelofs - Haematologica 2013 cited by 169

  22. Preconditioning allows engraftment of mouse and human embryonic lung cells, enabling lung repair in mice

    Authors: Chava Rosen, Elias Shezen, Anna Aronovich, Yael Klionsky, Yasmin Yaakov, Miri Assayag, Inbal Biton, Orna Tal, Guy Shakhar, H. Ben‐Hur, David Shneider, Zvi Vaknin, Oscar Sadan, Shmuel Evron, Enrique Freud, David Shoseyov, Michael Wilschanski, Neville Berkman, Willem E. Fibbe, David Hagin, Carmit Hillel-Karniel, Irit Milman Krentsis, Esther Bachar-Lustig, Yaīr Reisner - Nature Medicine 2015 cited by 129

  23. Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up

    Authors: Sander F. Rodrigo, Jan van Ramshorst, Georgette E. Hoogslag, Helèn Boden, Matthijs A. Velders, Suzanne C. Cannegieter, Helene Roelofs, Imad Al Younis, Petra Dibbets‐Schneider, Willem E. Fibbe, Jaap Jan Zwaginga, Jeroen J. Bax, Martin J. Schalij, Saskia L.M.A. Beeres, Douwe E. Atsma - Journal of Cardiovascular Translational Research 2013 cited by 105

  24. Sarcoma Derived from Cultured Mesenchymal Stem Cells

    Authors: Jakub Tolar, Alma J. Nauta, Mark J. Osborn, Angela Mortari, Ron McElmurry, Scott Bell, Lily Xia, Ning Zhou, Megan Riddle, Tania M. Schroeder, Jennifer J. Westendorf, R. Scott McIvor, Pancras C.W. Hogendoorn, Károly Szuhai, LeAnn Oseth, Betsy Hirsch, Stephen R. Yant, Mark A. Kay, Alexandra Peister, Darwin J. Prockop, Willem E. Fibbe, Bruce R. Blazar - Stem Cells 2006 cited by 639